back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Bookmark Bookmarked

DuPont Plans to Return Proceeds from Chemours Spinoff to Shareholders

Ellen Kullman, Chair of the Board and Chief Executive Officer at DuPont (figure: DuPont)

DuPont, Wilmington, DE/USA, announced fourth quarter 2014 operating earnings of USD 0.71 per share compared to USD 0.59 per share in the prior year. Fourth quarter results reflect a 20% increase in operating earnings per share year-over-year realized from a number of company actions, including strategic portfolio initiatives, continued productivity improvements related to the company’s operational redesign, reductions in performance-based compensation, and share repurchases.

Sales were USD 7.4 billion versus USD 7.7 billion in the same period last year, down 5% primarily due to portfolio changes and negative currency impacts. Volume grew in all segments except for Electronics & Communications. Segment operating earnings were $1,014 million, reflecting disciplined execution despite macroeconomic headwinds, including a weaker Ag economy and the impact from a stronger U.S. dollar.

For the full year 2014, DuPont delivered operating earnings of USD 4.01 per share compared to USD 3.88 per share in the prior year. Sales were USD 34.7 billion versus USD 35.7 billion last year, down 3% due to weakness in Ag markets,
portfolio changes and negative currency impacts. A 1% increase in volume was offset by price. Segment operating earnings of USD 6.0 billion increased 1 % versus USD 5.9 billion last year as the negative impact of portfolio changes and currency were more than offset by continued productivity improvements, lower performance-based compensation and gains from business divestitures.

"Our 2014 results demonstrate continued progress on our strategic plan to deliver higher growth and higher value, including ongoing portfolio refinement through several strategic portfolio actions and steady progress on the planned Chemours separation, substantial cost reductions from our operational redesign and productivity initiatives, and the continued return of capital to our shareholders through USD 2 billion of share repurchases and an increase in the common stock dividend of 4 percent," Ellen Kullman, Chair of the Board & Chief Executive Officer, said.

Expectations for Return of Capital from Chemours One-Time Dividend

The company has increased its cost reduction commitment from its operational redesign by approximately USD 300 million to at least USD 1.3 billion of total expected savings by 2017. Additionally, by the end of 2015, the company now expects annual run-rate savings of approximately USD 1 billion, significantly ahead of its previously announced schedule.

In addition the company said it expects to return all or substantially all of the one-time dividend proceeds from Chemours to DuPont shareholders via share repurchases over the 12 to 18 months following the separation of Chemours. Based on the target BB credit rating of Chemours, this amount is anticipated to be approximately USD 4 billion, pending the final credit ratings and underlying business conditions for Chemours.

"In 2015, we remain focused on generating superior returns for our shareholders, including through return of capital from the expected Chemours dividend, while positioning DuPont for our next stage of growth", Kullman said.

The separation of the Performance Chemicals segment from DuPont remains on track to be completed by mid-2015. Following its separation from DuPont, Chemours will be a new, publicly traded global leader in titanium dioxide, fluoroproducts and chemical solutions. The name reflects a focus on the science of chemistry and the heritage of the du Pont family origins in Nemours, France.

As announced in 2014, DuPont Executive Vice President Mark P. Vergnano will become President and Chief Executive Officer of Chemours. Mark E. Newman will serve as senior vice president and chief financial officer. BC Chong and Thierry F.J. Vanlancker will continue to lead the Titanium Technologies and the Fluoroproducts businesses, respectively. Chemours will have approximately 9,100 employees, 37 production facilities in 12 countries, and will serve over 5,000 customers worldwide.

Company profile

DuPont International Sàrl

2 chemin du Pavillon


Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here

Job Advertisements

Looking for a new challenge? Check out our jobs market!

Job Advertisements

Patents Stimulate Innovation

Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.